ArticleCancer medicine2023

Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open-label, multicenter, single-arm, phase 2 trial.

Shuang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.